Granulosin

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameGranulosin
Drug Alias Namegp91phox-transduced autologous hematopoietic stem cell therapy (Vision 7)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsGranulomatous Disease, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorld
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVision 7 Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVision 7 Gmbh
Active IndicationsN/A
Inactive IndicationsGranulomatous Disease, Chronic

Other Information

ATC CodeN/A
Related LinksN/A